Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Mar 20;12(3):341.
doi: 10.3390/v12030341.

Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy"

Liang-Tzung Lin  1   2
Affiliations
Editorial

Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy"

Liang-Tzung Lin. Viruses. .

Abstract

Members of the Morbillivirus genus are enveloped, negative-strand RNA viruses that include a number of highly contagious pathogens important to humans and animals. They are known to be transmitted via the respiratory route and cause febrile diseases that can be fatal. Despite the availability of attenuated vaccines against several members, these viruses remain responsible for significant morbidity and mortality in their natural hosts worldwide. The development of molecular biology techniques over the past decades has helped increase the understanding of morbillivirus pathogenesis and explore the possibility to engineer their genomes as viral vectors. This Special Issue of Viruses explores recent advances in recombinant morbilliviruses platforms, especially measles virus (MV) and canine distemper virus (CDV), for novel vaccine development and oncolytic virotherapy against cancers. Topics in this special issue include parameters involved during the viral vector production, strategies of viral vector engineering, and the underlying mechanisms of the therapeutic effects exhibited by these vectors.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Loewe D., Haussler J., Grein T.A., Dieken H., Weidner T., Salzig D., Czermak P. Forced Degradation Studies to Identify Critical Process Parameters for the Purification of Infectious Measles Virus. Viruses. 2019;11:725. doi: 10.3390/v11080725. - DOI - PMC - PubMed
    1. Ammour Y., Ryabaya O., Shchetinina Y., Prokofeva E., Gavrilova M., Khochenkov D., Vorobyev D., Faizuloev E., Shohin I., Zverev V.V., et al. The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus. Viruses. 2020;12:173. doi: 10.3390/v12020173. - DOI - PMC - PubMed
    1. Scheubeck G., Berchtold S., Smirnow I., Schenk A., Beil J., Lauer U.M. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus. Viruses. 2019;11:614. doi: 10.3390/v11070614. - DOI - PMC - PubMed
    1. Backhaus P.S., Veinalde R., Hartmann L., Dunder J.E., Jeworowski L.M., Albert J., Hoyler B., Poth T., Jager D., Ungerechts G., et al. Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists. Viruses. 2019;11:914. doi: 10.3390/v11100914. - DOI - PMC - PubMed
    1. Busch E., Kubon K.D., Mayer J.K.M., Pidelaserra-Martí G., Albert J., Hoyler B., Heidbuechel J.P.W., Stephenson K.B., Lichty B.D., Osen W., et al. Measles Vaccines Designed for Enhanced CD8+ T Cell Activation. Viruses. 2020;12:242. doi: 10.3390/v12020242. - DOI - PMC - PubMed

Publication types

LinkOut - more resources